This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Results of Bishydroxycoumarin Therapy as It Is Practiced in a Private Hospital

L. FELDMAN, M.D.; G. L. SCHAEFER, M.D.; S. E. GOLDSTEIN, M.D.; I. M. FORMAN, M.D.

AMA Arch Intern Med. 1954;94(3):433-437.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

FOLLOWING the animal experimentation by Solandt, Nassim, and Best * on the prevention of mural thrombi formation and extension of coronary thrombosis with the use of heparin and following the synthesis of bishydroxycoumarin (Dicumarol), many reports appeared in the literature favoring the use of bishydroxycoumarin therapy in myocardial infarction. The routine use of bishydroxycoumarin in myocardial infarctions was advocated by Wright and associates in their report of the Committee for Evaluation of Anticoagulants in the Treatment of Coronary Thrombosis with Mycardial Infarction, under the auspices of the American Heart Association. More recently however, many reports have appeared questioning the routine use of anticoagulants in the treatment of myocardial infarction.

It was our purpose, in undertaking this study, to determine the results of anticoagulant therapy in myocardial infarction as it is carried out in a private hospital, in the daily practice of various physicians, as internists, cardiologists, and general . . . [Full Text PDF of this Article]

Author Affiliations
CHICAGO; DECATUR, ILL.; CHICAGO

From the Department of Medicine, Mount Sinai Hospital.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?